SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback